HIV reproduction inhibition by amino acid and dipeptide derivatives of fullerene C60

Antibiotiki i Khimioterapiya

Volumn 49, Issue 12, 2004, Pages 3-8

  Miller, G G ^a   Romanova, V S ^a   Pokidysheva, L N ^a   Titova, I V ^a   Kaliberda, E N ^a   Rumsh, L D ^a   Andreeva, O I ^a   Rybalkin, N P ^a  

^a NONE

Author keywords

Amino acid derivatives; Dipeptide derivatives; Fullerene C60; HIV; Inhibition; Reproduction

Indexed keywords

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; MUS; ORYCTOLAGUS CUNICULUS;

AMINO ACID; DIPEPTIDE; FULLERENE C60; FULLERENE DERIVATIVE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ANIMAL; ARTICLE; CELL LINE; CHEMISTRY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MOUSE; PHYSIOLOGY; VIRUS REPLICATION;

AMINO ACIDS; ANIMALS; CELL LINE; DIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; FULLERENES; HIV PROTEASE INHIBITORS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MICE; REVERSE TRANSCRIPTASE INHIBITORS; VIRUS REPLICATION;

EID: 24044503406     PISSN: 02352990     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Wilson S. R. Biological aspects of fullerenes. Fullerenes: Chemistry, Physics and Technology / eds. by Kadish&Ruoff, New-York, 2000; 437-465.
2. Tokuyama H., Nakamura S., Nakamura E. Photoinduced biochemical activity of fullerene carboxylic acid. J Am Chem Soc 1993; 115: 7918-7922.
3. Yamakoshi Y. N., Yagami T., Furuhara K. et al. The physiological activity of compounds containing fullerene derivatives. J Chem Soc Chem Commun 1994; 4: 517-523.
4. Russian source
5. Nakamura E., Tokuyama H, Yamago S. et al. Biological activity of water-soluble fullerenes. Structural dependence of DNA cleavage, cytotoxicity and enzyme inhibitory activities including HIV-protease inhibition. Bull Chem Soc Jpn 1996; 69: 2143-2151.
6. Friedman S., DeCamp D. L., Sijbesma R. P., et al. Inhibition of the HIV-1 protease by fullerene derivatives: model building studies and experimental verification. J Am Chem Soc 1993; 115: 6506-6509.
7. Sijbesma R., Srdanov G., Wudl F. et al. Synthesis of a fullerene derivative for the inhibition of HIV enzymes. Ibid; 6510-6512.
8. Schinazi R., Chiang L., Wilson L. et al. Anti-human immunodeficiency virus activity of polyhydroxy fullerenes in vitro. Electrochem Soc Proc 1997; 97-14: 357-360.
9. Friedman S., Ganapathi P. S., Rubin Y., Kenyon G. Optimizing the binding of fullerene inhibition of the HIV-1 protease through predicted increases in hydrophobic desolvation. J Med Chem 1998; 41: 2424-2429.
10. 60. J Nanoparticle Res 2003: 5: 561-566.
11. Miller G. G., Romanova V. S., Kushch A. A. et al. New effective compounds for HIV proteinase inhibition. Antiviral Res 2002; 53: 3: 25; A4.
12. Russian source
13. Russian source
14. Russian source
15. Dulbecco R. Virology. Philadelphia, 2nd ed, 1988, 22-25.
16. Russian source
17. Russian source
18. Russian source
19. Russian source
20. Russian source
21. Russian source
22. 60 fullerene in nonaqueous solution. Mendeleev Commun 1996; 171-173.